Myoinositol and Metformin in the Prevention of Gestational Diabetes in High-Risk Patients: A Narrative Review

Author:

Romeo Paola1,D’Anna Rosario1,Corrado Francesco1

Affiliation:

1. Obstetrics and Gynecology Unit, Department of Human Pathology, University of Messina (Italy), Via Consolare Valeria, 1, 98125 Messina, Italy

Abstract

Our hypothesis is that myoinositol and metformin in pregnant women with high-risk factors for glucose intolerance would reduce insulin resistance and consequently lower the incidence of gestational diabetes mellitus (GDM), a metabolic disorder of pregnancy characterized by maternal hyperglycemia due to deficient response to physiological insulin resistance, which may have a negative impact on perinatal outcome and long-term sequelae. In recent years, this pathology has become increasingly important given the global obesity epidemic and the delay in becoming pregnant, especially in industrialized countries. For this reason, the attempt to prevent, rather than cure, gestational diabetes is particularly important. In addition to lifestyle changes (especially diet and doing more exercise), myoinositol and metformin are the most promising factors at the moment, although not all RCTs published so far agree on their real effectiveness. A review of the articles published so far allows us to assume, albeit with some distinctions, that they can play a positive role.

Publisher

MDPI AG

Reference48 articles.

1. American Diabetes Association (2019). Classification and diagnosis of diabetes: Standard of medical care in diabetes. Diabetes Care, 42, 513–528.

2. Gestational diabetes: The consequences of not treating;Langer;Am. J. Obstet. Gynec.,2005

3. Gestational diabetes and the risk of cardiovascular disease in women: A systematic review and meta-analysis;Kramer;Diabetologia,2019

4. Progression to type 2 diabetes in women with a known history of gestational diabetes: Systematic review and meta-analysis;Vounzoulaki;BMJ,2020

5. Birth weight and parental BMI predict overweight in children from mother with gestational diabetes;Pawliczak;Diabetes Care,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3